Skip to content

Insider · CIK 0002124509

Anthony Mancini

officer

Files at RVMD (Revolution Medicines, Inc.). First filing Mar 26, 2026, latest Sep 28, 2026.

Anthony Mancini files SEC Form 4 as officer at RVMD (Revolution Medicines, Inc.). Since Mar 26, 2026, Anthony Mancini has reported 0 open-market buys worth $0 and 8 open-market sells worth $9.8M, the latest filed on Sep 28, 2026.

A track record needs three past buys with six months of prices behind them; Anthony Mancini has 0, so none is measured yet.

The newest scored trade: sold $743k of RVMD on Sep 24, 2026, filed Sep 28, 2026, scored 16 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 8 sells worth $9.8M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $9.8M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RVMD: Revolution Medicines, Inc.

RVMDOct 9, 2026 · close 189.76

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
16Weak
RVMDsell 810b5-1
Revolution Medicines, Inc.
$743k
3,708 shares
-9%+370% from low-10% from high
25Weak
RVMDsell 910b5-1
Revolution Medicines, Inc.
$347k
1,764 shares
-4%+349% from low-14% from high
25Weak
RVMDsell 910b5-1
Revolution Medicines, Inc.
$353k
1,774 shares
-4%+361% from low-11% from high
30Weak
RVMDsell 910b5-1
Revolution Medicines, Inc.
$3.2M
15,448 shares
-26%+403% from low-8% from high
51Moderate
RVMDsell 6
Revolution Medicines, Inc.
$720k
4,615 shares
-8%+351% from low-4% from high
0Weak
RVMDsell10b5-1
Revolution Medicines, Inc.
$481k
3,121 shares
-5%+346% from low0% from high
4Weak
RVMDsell 210b5-1
Revolution Medicines, Inc.
$413k
3,120 shares
-5%+279% from low-14% from high
30Weak
RVMDsell 810b5-1
Revolution Medicines, Inc.
$3.6M
37,450 shares
-41%+203% from low-24% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Sep 25, 2026 RVMD
Revolution Medicines, Inc.
9,363
0.00% of outstanding
$1.9MSep 25, 2026$4.0M
Sep 24, 2026 RVMD
Revolution Medicines, Inc.
587
0.00% of outstanding
$112kSep 24, 2026$3.9M
Sep 18, 2026 RVMD
Revolution Medicines, Inc.
1,764
0.00% of outstanding
$347kSep 18, 2026$3.5M
Sep 15, 2026 RVMD
Revolution Medicines, Inc.
2,377
0.00% of outstanding
$484kSep 15, 2026$3.9M
Sep 10, 2026 RVMD
REVOLUTION MEDICINES INC
15,448
0.01% of outstanding
$3.2MSep 10, 2026$720k
Jun 15, 2026 RVMD
Revolution Medicines, Inc.
4,211
0.00% of outstanding
$648kJun 15, 2026$4.5M
May 26, 2026 RVMD
REVOLUTION MEDICINES INC
3,121
0.00% of outstanding
$473kMay 26, 2026$4.0M
Apr 27, 2026 RVMD
REVOLUTION MEDICINES INC
3,120
0.00% of outstanding
$422kApr 27, 2026$3.6M
Mar 26, 2026 RVMD
Revolution Medicines, Inc.
37,450
0.02% of outstanding
$3.6MMar 25, 2026none

Transactions

Every row this insider has filed, 32 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 24, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-587$200.00$117k39,76515 d ago
Sep 25, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+3,121$33.62$105k42,88615 d ago
Sep 25, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-3,121$200.54$626k39,76515 d ago
Sep 25, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-3,121$0.00$093,62515 d ago
Sep 18, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-1,764$196.94$347k40,35221 d ago
Sep 16, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-27$195.05$5,26643,86325 d ago
Sep 16, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-1,747$199.30$348k42,11625 d ago
Sep 10, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+9,363$33.62$315k59,33829 d ago
Sep 10, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-6,019$203.28$1.2M53,31929 d ago
Sep 10, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-5,530$204.14$1.1M47,78929 d ago
Sep 10, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-2,420$205.05$496k45,36929 d ago
Sep 10, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-1,179$206.10$243k44,19029 d ago
Sep 10, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-300$207.17$62k43,89029 d ago
Sep 10, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-9,363$0.00$096,74629 d ago
Jun 16, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock
-4,615$156.12$720k49,975Jun 18, 2026
May 26, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+3,121$33.62$105k57,521May 28, 2026
May 26, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-700$153.30$107k56,821May 28, 2026
May 26, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-2,000$154.06$308k54,821May 28, 2026
May 26, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-421$154.82$65k54,400May 28, 2026
May 26, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-3,121$0.00$0106,109May 28, 2026
Apr 27, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+3,120$33.62$105k57,520Apr 29, 2026
Apr 27, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-1,671$131.66$220k55,849Apr 29, 2026
Apr 27, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-1,049$132.88$139k54,800Apr 29, 2026
Apr 27, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-400$134.34$54k54,400Apr 29, 2026
Apr 27, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-3,120$0.00$0109,230Apr 29, 2026
Mar 25, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Common Stock10b5-1
+37,450$33.62$1.3M91,850Mar 26, 2026
Mar 25, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-1,800$93.22$168k90,050Mar 26, 2026
Mar 25, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-3,128$94.16$295k86,922Mar 26, 2026
Mar 25, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-21,086$95.49$2.0M65,836Mar 26, 2026
Mar 25, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-11,036$96.43$1.1M54,800Mar 26, 2026
Mar 25, 2026RVMD
Revolution Medicines, Inc.
SOpen-market sale
Common Stock10b5-1
-400$97.21$39k54,400Mar 26, 2026
Mar 25, 2026RVMD
Revolution Medicines, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-37,450$0.00$0112,350Mar 26, 2026

Questions about Anthony Mancini

Answered from the filings on this page, as of the latest one.

Is Anthony Mancini buying or selling?

In the last 12 months Anthony Mancini reported 0 open-market buys worth $0 and 8 open-market sells worth $9.8M on SEC Form 4; the latest was sold $743k of RVMD on Sep 24, 2026. Grants, option exercises and tax withholding are not counted.

How did Anthony Mancini's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anthony Mancini has 0.

Where does Anthony Mancini file Form 4?

Anthony Mancini has filed Form 4 at RVMD (Revolution Medicines, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Anthony Mancini: insider trades and track record | InsiderTell